Thomas Edward Hamilton, Director at Larimar Therapeutics, Inc. (LRMR), bought 114,416 shares at $8.74 ($1000K) on 2024-02-16, disclosed to the SEC on 2024-05-31.
Open-market purchase of $1000k LRMR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.74 | 57,208 | $500K | 50.0% |
| 2 | $8.74 | 57,208 | $500K | 50.0% |
| Total | $8.74 avg | 114,416 | $1000K | 100% |
| Filing → |
| LRMR | BUY | 2022-09-20 | $1000K | — | Filing → |
| LRMR | BUY | 2021-07-02 | $992K | — | Filing → |
| NLY | SELL | 2021-05-04 | $734K | — | Filing → |